Particle.news
Download on the App Store
13 ARTICLES
·
4d ago

Michigan Medicine Stops Puberty Blockers and Hormones for Under-19 Patients Under DOJ Scrutiny

Federal subpoenas and funding threats are pushing hospitals to curb youth transition care.

The Storm family’s cork board in their kitchen in San Francisco.
Tristan Storm, left, and Calder Storm hang out with their children in their living room in San Francisco on Friday.
Calder Storm, left, and Tristan Storm, right, parents of two teens, one who is nonbinary and one who is a transgender girl, pose for a portrait in their home in San Francisco on Friday.
Calder Storm, left, Tristan Storm and their children play a family board game on Friday in San Francisco.

Overview

  • The University of Michigan’s health system said it halted puberty blockers and gender‑affirming hormones for minors after receiving a Justice Department subpoena and citing escalating legal and regulatory risks.
  • The decision places Michigan Medicine among more than 20 hospitals and health systems that have paused or scaled back transition-related care for patients under 19.
  • A subpoena filed in court shows the DOJ is seeking extensive records on youth care back to January 2020, including patient identifiers such as Social Security numbers, raising privacy concerns.
  • Attorneys general from 16 states have sued, arguing the federal campaign unlawfully intimidates providers where care remains legal, and Children’s Hospital of Philadelphia has asked a court to block demands for patient data.
  • The federal push also features an OPM plan to end transition-related coverage in 2026, an HHS grant cancellation in California, FTC and CMS inquiries, and an FBI request for public tips.